154 related articles for article (PubMed ID: 7913670)
1. Analysis of c-fos, c-jun, c-erbB1, c-erbB2 and c-myc in primary lung carcinomas and their lymph node metastases.
Volm M; van Kaick G; Mattern J
Clin Exp Metastasis; 1994 Jul; 12(4):329-34. PubMed ID: 7913670
[TBL] [Abstract][Full Text] [Related]
2. Expression of oncoproteins in primary human non-small cell lung cancer and incidence of metastases.
Volm M; Drings P; Wodrich W; van Kaick G
Clin Exp Metastasis; 1993 Jul; 11(4):325-9. PubMed ID: 8100491
[TBL] [Abstract][Full Text] [Related]
3. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
Volm M; Mattern J
Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
[TBL] [Abstract][Full Text] [Related]
4. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
Volm M; Efferth T; Mattern J
Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of oncoproteins in non-small cell lung carcinomas of smokers.
Wodrich W; Volm M
Carcinogenesis; 1993 Jun; 14(6):1121-4. PubMed ID: 8389672
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas.
Volm M; Drings P; Wodrich W
J Cancer Res Clin Oncol; 1993; 119(9):507-10. PubMed ID: 8100821
[TBL] [Abstract][Full Text] [Related]
7. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
Volm M; Kästel M; Mattern J; Efferth T
Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
Volm M
Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
[TBL] [Abstract][Full Text] [Related]
9. Effects of cadmium on hepatocellular DNA damage, proto-oncogene expression and apoptosis in rats.
Yu RA; He LF; Chen XM
Biomed Environ Sci; 2007 Apr; 20(2):146-53. PubMed ID: 17624190
[TBL] [Abstract][Full Text] [Related]
10. Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related proto-oncogenes (c-jun, c-fos, c-myc, bax, bcl-2, and bcl-x) in the hamster uterus.
Zheng X; Hendry WJ
Cell Growth Differ; 1997 Apr; 8(4):425-34. PubMed ID: 9101088
[TBL] [Abstract][Full Text] [Related]
11. Effect of Qi-protecting powder (Huqi San) on expression of c-jun, c-fos and c-myc in diethylnitrosamine-mediated hepatocarcinogenesis.
Li X; Shi ZM; Feng P; Wen ZY; Wang XJ
World J Gastroenterol; 2007 Aug; 13(31):4192-8. PubMed ID: 17696247
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.
Volm M; Rittgen W; Drings P
Br J Cancer; 1998 Feb; 77(4):663-9. PubMed ID: 9484827
[TBL] [Abstract][Full Text] [Related]
13. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of male Wistar rats injected i.v. with toxins.
Li H; Xie P; Li G; Hao L; Xiong Q
Toxicon; 2009 Jan; 53(1):169-75. PubMed ID: 19041662
[TBL] [Abstract][Full Text] [Related]
14. Correlated expression of glutathione S-transferase-pi and c-Jun or other oncogene products in human squamous cell carcinomas of the head and neck: relevance to relapse after radiation therapy.
Miura K; Suzuki S; Tanita J; Shinkawa H; Satoh K; Tsuchida S
Jpn J Cancer Res; 1997 Feb; 88(2):143-51. PubMed ID: 9119742
[TBL] [Abstract][Full Text] [Related]
15. Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas.
Yokoyama Y; Sagara M; Sato S; Saito Y
Gynecol Oncol; 1998 Mar; 68(3):280-7. PubMed ID: 9570981
[TBL] [Abstract][Full Text] [Related]
16. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
Soini Y; Mannermaa A; Winqvist R; Kamel D; Poikonen K; Kiviniemi H; Pääkkö P
J Histochem Cytochem; 1994 Jun; 42(6):795-803. PubMed ID: 7910618
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
[TBL] [Abstract][Full Text] [Related]
18. Oncogene expression in carotid body tumors.
Wang DG; Barros D'Sa AA; Johnston CF; Buchanan KD
Cancer; 1996 Jun; 77(12):2581-7. PubMed ID: 8640709
[TBL] [Abstract][Full Text] [Related]
19. Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas.
Volm M; Koomagi R; Kaufmann M; Mattern J; Stammler G
Clin Exp Metastasis; 1996 May; 14(3):209-14. PubMed ID: 8674274
[TBL] [Abstract][Full Text] [Related]
20. Differential c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance.
Riva C; Lavieille JP; Reyt E; Brambilla E; Lunardi J; Brambilla C
Eur J Cancer B Oral Oncol; 1995 Nov; 31B(6):384-91. PubMed ID: 8746269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
